Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

(Abstracted from Anesthesiology, 126:12–15, 2017) This editorial provides an overview of why sugammadex should be preferred for the reversal of neuromuscular block, especially now that it has US Food and Drug Administration approval, as well as highlighting the need for neuromuscular blockade monitoring.
Source: Survey of Anesthesiology - Category: Anesthesiology Tags: Techniques and Monitoring Source Type: research